Erin P. Foff
Acadia Pharmaceuticals (United States)(US)Université Toulouse III - Paul Sabatier(FR)Inserm(FR)Banner Sun Health Research Institute(US)
Publications by Year
Research Areas
Schizophrenia research and treatment, Parkinson's Disease Mechanisms and Treatments, Mental Health and Psychiatry, Cholinesterase and Neurodegenerative Diseases, Neurological Disorders and Treatments
Most-Cited Works
- → Trial of Pimavanserin in Dementia-Related Psychosis(2021)127 cited
- → Pimavanserin: Potential Treatment For Dementia-Related Psychosis(2018)83 cited
- → Therapeutics development in myotonic dystrophy type 1(2011)49 cited
- → EEG Findings May Serve as a Potential Biomarker for Anti–NMDA Receptor Encephalitis(2016)44 cited
- → TWEAK/Fn14, a pathway and novel therapeutic target in myotonic dystrophy(2014)41 cited
- → Evaluation of the efficacy of pimavanserin in the treatment of agitation and aggression in patients with Alzheimer's disease psychosis: A post hoc analysis(2020)20 cited